These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15800796)

  • 21. A chemistry set for life.
    Gura T
    Nature; 2000 Sep; 407(6802):282-4. PubMed ID: 11014160
    [No Abstract]   [Full Text] [Related]  

  • 22. [Active small-molecule compounds and leukemia: approach from chemical biology].
    Chen GQ
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1369-71. PubMed ID: 17785052
    [No Abstract]   [Full Text] [Related]  

  • 23. American Chemical Society: chemical reaction.
    Marris E
    Nature; 2005 Oct; 437(7060):807-9. PubMed ID: 16208339
    [No Abstract]   [Full Text] [Related]  

  • 24. Call for papers! A special thematic compilation/special issue crossover with ACS Chemical Biology, ACS Medicinal Chemistry Letters, and the Journal of Medicinal Chemistry focused on new frontiers in kinases.
    Benovic JL; Armstrong RN
    Biochemistry; 2014 Mar; 53(11):1723. PubMed ID: 24660987
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted agents for advanced thyroid cancer: "knowledge is power" - the role of multikinase inhibitors.
    Mangano A; Kim HY; Lianos GD; Roukos DH; Dionigi G
    Future Oncol; 2014 Nov; 10(14):2099-102. PubMed ID: 25471022
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent developments in isocyanide based multicomponent reactions in applied chemistry.
    Dömling A
    Chem Rev; 2006 Jan; 106(1):17-89. PubMed ID: 16402771
    [No Abstract]   [Full Text] [Related]  

  • 27. Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.
    Tang J; Hamajima T; Nakano M; Sato H; Dickerson SH; Lackey KE
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4610-4. PubMed ID: 18662874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gimatecan (sigma-tau industrie farmaceutiche riunite/novartis).
    Nitiss JL; Nitiss KC
    IDrugs; 2005 Jul; 8(7):578-88. PubMed ID: 15973567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of analogues of the anti-tumor alkaloid naamidine A.
    Aberle N; Catimel J; Nice EC; Watson KG
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3741-4. PubMed ID: 17462892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of natural products on developing new anti-cancer agents.
    Cragg GM; Grothaus PG; Newman DJ
    Chem Rev; 2009 Jul; 109(7):3012-43. PubMed ID: 19422222
    [No Abstract]   [Full Text] [Related]  

  • 32. Dealing with a data dilemma.
    Nat Rev Drug Discov; 2008 Aug; 7(8):632-3. PubMed ID: 18670425
    [No Abstract]   [Full Text] [Related]  

  • 33. Scientific databases. NIH, chemical society look for common ground.
    Kaiser J
    Science; 2005 Sep; 309(5740):1473. PubMed ID: 16141038
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical biomarkers of kinase activity: examples from EGFR inhibition trials.
    Krause M; Baumann M
    Cancer Metastasis Rev; 2008 Sep; 27(3):387-402. PubMed ID: 18427731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
    Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved mechanism-based cross-linker for multiplexed kinase detection and inhibition in a complex proteome.
    Liu K; Kalesh KA; Ong LB; Yao SQ
    Chembiochem; 2008 Aug; 9(12):1883-8. PubMed ID: 18624293
    [No Abstract]   [Full Text] [Related]  

  • 37. In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives.
    Rossignol E; Debiton E; Fabbro D; Moreau P; Prudhomme M; Anizon F
    Anticancer Drugs; 2008 Sep; 19(8):789-92. PubMed ID: 18690090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases.
    Graczyk PP
    J Med Chem; 2007 Nov; 50(23):5773-9. PubMed ID: 17948979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical genetic approaches to kinase drug discovery.
    Gallion SL; Qian D
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):638-45. PubMed ID: 16159026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.